"Northwestern Medicine is proud to have 4 hospitals ranked among “America’s Best” by U.S. News & World report, 2018-19. Anchored by Northwestern Memorial Hospital, the #1 hospital in Illinois for seven straight years, we’re leading the quest for better care and better treatments in the Chicagoland area. With more than 200 locations across Chicagoland, better care and better treatments are never far from home. To learn more, visit our website."

During the past decade, Cognitive Neurology and Alzheimer's Disease Center - Northwestern University conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Cognitive Neurology and Alzheimer's Disease Center - Northwestern University" #1 collaborator was "National Institute on Aging (NIA)" with 2 trials as a collaborator and "Emory University" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Cognitive Neurology and Alzheimer's Disease Center - Northwestern University" are "Primary Progressive Aphasia" (4 trials), "Alzheimer Disease" (2 trials), "Caregiver Burnout" (1 trials), "Dementia" (1 trials) and "Primary Progressive Aphasia With Suspected Alzheimer's Disease" (1 trials). Many other conditions were trialed in "Cognitive Neurology and Alzheimer's Disease Center - Northwestern University" in a lesser frequency.

Most popular intervention types in "Cognitive Neurology and Alzheimer's Disease Center - Northwestern University" are "Device" (3 trials), "Drug" (3 trials) and "Behavioral" (2 trials). Other intervention types were less common.

The name of intervention was led by "PET" (2 trials), "18F-AV-1451" (1 trials), "Communication Bridge™" (1 trials), "Evidence-Based Impairment Focused" (1 trials) and "Florbetaben F18" (1 trials). Other intervention names were less common.

The vast majority of trials in "Cognitive Neurology and Alzheimer's Disease Center - Northwestern University" are 5 trials for "All" genders.

Currently, there are NaN active trials in "Cognitive Neurology and Alzheimer's Disease Center - Northwestern University". undefined are not yet recruiting, 2 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Cognitive Neurology and Alzheimer's Disease Center - Northwestern University, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Cognitive Neurology and Alzheimer's Disease Center - Northwestern University, 1 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".